We are live on
!
Find out more
M&T Bank Portfolio holdings
AUM
$29.2B
1-Year Est. Return
22.81%
This Fund
S&P 500
This Quarter
Est. Return
-0.08%
1 Year Est. Return
+22.81%
3 Year Est. Return
+65.66%
5 Year Est. Return
+77.58%
10 Year Est. Return
+258.18%
AUM
$29.2B
AUM Growth
-$1.93B
(-6.2%)
Cap. Flow
-$1.4B
Cap. Flow
% of AUM
-4.78%
Top 10 Holdings %
Top 10 Hldgs %
29.53%
Holding
1,805
New
98
Increased
492
Reduced
1,031
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$44.9M |
| 2 |
Vanguard Value ETF
VTV
|
+$17M |
| 3 |
AT&T
T
|
+$16.2M |
| 4 |
Vanguard Total Bond Market
BND
|
+$13.3M |
| 5 |
Vanguard Growth ETF
VUG
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
M&T Bank
MTB
|
+$190M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$72.1M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$52.6M |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$51.9M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$46.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.35% |
| 2 | Financials | 7.95% |
| 3 | Healthcare | 6.4% |
| 4 | Industrials | 5.62% |
| 5 | Communication Services | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Dover
DOV
$27.2B
| $25.4M | 0.09% |
121,740
-759
| -0.6% | -$162K |
|
177
TotalEnergies
TTE
$193B
| $25.3M | 0.09% |
276,976
-1,780
| -0.6% | -$136K |
|
178
Gilead Sciences
GILD
$161B
| $25.2M | 0.09% |
180,912
-10,229
| -5% | -$1.43M |
|
179
VICI Properties
VICI
$29.4B
| $24.5M | 0.08% |
896,997
-80,994
| -8% | -$2.32M |
|
180
AstraZeneca
AZN
$263B
| $24.5M | 0.08% |
124,179
+17,298
| +16% | +$3.34M |
|
181
PACCAR
PCAR
$69.6B
| $24.4M | 0.08% |
211,172
-17,644
| -8% | -$2.13M |
|
182
Goldman Sachs
GS
$313B
| $23.7M | 0.08% |
28,068
-310
| -1% | -$277K |
|
183
Advanced Micro Devices
AMD
$851B
| $23.3M | 0.08% |
114,739
+3,371
| +3% | +$720K |
|
184
Moody's
MCO
$81.7B
| $23.2M | 0.08% |
53,083
-1,384
| -3% | -$655K |
|
185
Enterprise Products Partners
EPD
$83.8B
| $23M | 0.08% |
607,785
-8,963
| -1% | -$317K |
|
186
Colgate-Palmolive
CL
$72.6B
| $22.7M | 0.08% |
266,101
-7,136
| -3% | -$636K |
|
187
Vanguard Health Care ETF
VHT
$18.2B
| $22.7M | 0.08% |
83,197
-12,840
| -13% | -$3.67M |
|
188
Regions Financial
RF
$26.3B
| $22.6M | 0.08% |
866,968
-57,666
| -6% | -$1.61M |
|
189
Schwab US REIT ETF
SCHH
$11.7B
| $22.5M | 0.08% |
1,046,422
| – | – |
|
190
Zoetis
ZTS
$31.6B
| $22.5M | 0.08% |
190,061
-15,754
| -8% | -$1.95M |
|
191
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.96B
| $22.3M | 0.08% |
468,577
-360,378
| -43% | -$17.3M |
|
192
Capital One
COF
$124B
| $22.2M | 0.08% |
121,648
-5,003
| -4% | -$1.05M |
|
193
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
| $22.2M | 0.08% |
151,996
-6,480
| -4% | -$962K |
|
194
Lam Research
LRCX
$382B
| $21.8M | 0.07% |
101,892
+7,188
| +8% | +$1.61M |
|
195
iShares Gold Trust
IAU
$63B
| $21.3M | 0.07% |
242,052
-78,924
| -25% | -$7.24M |
|
196
iShares Russell Top 200 Growth ETF
IWY
$16B
| $21.1M | 0.07% |
84,816
-3,637
| -4% | -$964K |
|
197
Micron Technology
MU
$1.04T
| $20.7M | 0.07% |
61,320
-2,579
| -4% | -$1.01M |
|
198
McKesson
MCK
$98.5B
| $20.6M | 0.07% |
23,846
-500
| -2% | -$446K |
|
199
Sanofi
SNY
$104B
| $20.6M | 0.07% |
426,657
+952
| +0.2% | +$44.4K |
|
200
Digital Realty Trust
DLR
$73.7B
| $20.3M | 0.07% |
112,665
+189
| +0.2% | +$32.3K |
|
Similar funds
M&T Bank's Q1 2026 Portfolio in Review
As of Q1 2026, M&T Bank held 1,805 positions worth $29.2B, down 6.2% from $31.1B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
M&T Bank withdrew a net $1.4B in Q1 2026, closing 92 positions and reducing 1,031 holdings. Its most notable exit was CyberArk, an estimated $1.74M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, M&T Bank opened a new position in Teva Pharmaceuticals worth $2.97M.
- M&T Bank's largest Q1 2026 buy was Teva Pharmaceuticals: 98,463 shares worth $2.97M.
- M&T Bank added most to iShares Russell 1000 Growth ETF in Q1 2026, an estimated $44.9M increase.
- M&T Bank's biggest Q1 2026 reduction was M&T Bank, cutting an estimated $190M.
- M&T Bank fully exited CyberArk in Q1 2026, selling an estimated $1.74M.
- M&T Bank's ten largest holdings make up 30% of its $29.2B portfolio in Q1 2026.
- M&T Bank opened 98 new positions and closed 92 in Q1 2026.
- M&T Bank's portfolio value fell 6.2% quarter-over-quarter to $29.2B.
Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.